Literature DB >> 17192350

Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.

Maciej T Malecki1, Jan Skupien, Tomasz Klupa, Krzysztof Wanic, Wojciech Mlynarski, Agnieszka Gach, Iwona Solecka, Jacek Sieradzki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17192350     DOI： 10.2337/dc06-1628

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  12 in total

Review 1.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

Review 2.  Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations.

Authors:  Lisa R Letourneau; Siri Atma W Greeley
Journal:  Curr Diab Rep       Date:  2019-06-27       Impact factor: 4.810

3.  The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.

Authors:  Joseph C Koster; Francesco Cadario; Cinzia Peruzzi; Carlo Colombo; Colin G Nichols; Fabrizio Barbetti
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

Review 4.  Neonatal diabetes mellitus.

Authors:  Lydia Aguilar-Bryan; Joseph Bryan
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 5.  Monogenic models: what have the single gene disorders taught us?

Authors:  Tomasz Klupa; Jan Skupien; Maciej T Malecki
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

6.  Smart sensors and virtual physiology human approach as a basis of personalized therapies in diabetes mellitus.

Authors:  Carlos M Fernández Peruchena; Manuel Prado-Velasco
Journal:  Open Biomed Eng J       Date:  2010-08-08

7.  Neonatal diabetes with end-stage nephropathy: pancreas transplantation decision.

Authors:  Enric Esmatjes; Amanda Jimenez; Gonzalo Diaz; Mireia Mora; Roser Casamitjana; G Pérez de Nanclares; Luis Castaño; Maria José Ricart
Journal:  Diabetes Care       Date:  2008-08-04       Impact factor: 17.152

8.  The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes.

Authors:  Veronica Lang; Peter E Light
Journal:  Pharmgenomics Pers Med       Date:  2010-11-24

9.  Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion.

Authors:  Wojciech Fendler; Iwona Pietrzak; Melissa F Brereton; Carolina Lahmann; Mariusz Gadzicki; Malgorzata Bienkiewicz; Izabela Drozdz; Maciej Borowiec; Maciej T Malecki; Frances M Ashcroft; Wojciech M Mlynarski
Journal:  Diabetes Care       Date:  2013-03-05       Impact factor: 19.112

10.  Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene.

Authors:  Praveen Chakravarthi Veeraragavulu; Nanda Kumar Yellapu; Sireesha Yerrathota; Pradeepkiran Jangampalli Adi; Bhaskar Matcha
Journal:  ACS Omega       Date:  2019-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.